BRAF inhibitor-induced panniculitis in patients treated for stage IV metastatic melanoma: a case series.
Skeletal Radiol
; 50(6): 1257-1262, 2021 Jun.
Article
em En
| MEDLINE
| ID: mdl-33165713
ABSTRACT
BRAF and MEK inhibitor combination therapy is the standard treatment for patients with BRAF V600E mutant metastatic melanoma. Neutrophilic panniculitis is a known rare complication of BRAF inhibitor therapy and can act as a potential mimic of melanoma metastases on 18F-FDG PET/CT. In this case series, we present three cases of BRAF inhibitor-induced panniculitis in patients being treated for BRAF-mutant metastatic melanoma and emphasize the use of ultrasound to differentiate between panniculitis lesions, which are typically ill-defined echogenic masses and subcutaneous soft tissue melanoma metastases, which present as hypoechoic vascular masses.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Cutâneas
/
Paniculite
/
Melanoma
Limite:
Humans
Idioma:
En
Revista:
Skeletal Radiol
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Estados Unidos